Selection of New Probiotics for Endometrial Health
Microbiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on i...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/full |
id |
doaj-adebfa32593b460dbe2f6edd9f7e0daa |
---|---|
record_format |
Article |
spelling |
doaj-adebfa32593b460dbe2f6edd9f7e0daa2020-11-25T01:58:50ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882019-04-01910.3389/fcimb.2019.00114448143Selection of New Probiotics for Endometrial HealthEmpar Chenoll0Inmaculada Moreno1Inmaculada Moreno2María Sánchez3Iolanda Garcia-Grau4Iolanda Garcia-Grau5Ángela Silva6Marta González-Monfort7Salvador Genovés8Felipe Vilella9Cristina Seco-Durban10Carlos Simón11Carlos Simón12Carlos Simón13Carlos Simón14Daniel Ramón15Biopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainIgenomix SL, Research Department, Paterna, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainDepartment of Obstetrics and Gynecology, University of Valencia, Valencia, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix SL, Research Department, Paterna, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainFerring Pharmaceuticals, Madrid, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainIgenomix SL, Research Department, Paterna, SpainDepartment of Obstetrics and Gynecology, University of Valencia, Valencia, SpainDepartment of Obstetrics and Gynecology, School of Medicine, Stanford University, Palo Alto, CA, United StatesBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainMicrobiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on its capacity to initially lower pH and to promote the reduction of pathogenic bacteria. Based on this rationale, strain Lactobacillus rhamnosus BPL005 was initially selected for its capacity to reduce in vitro pH levels and produce organic acids. Subsequently, strain L. rhamnosus BPL005 (CECT 8800) was demonstrated to have a protective role on endometrial infections in an in vitro model of bacterial colonization of primary endometrial epithelial cells with Atopobium vaginae, Gardnerella vaginalis, Propionibacterium acnes, and Streptococcus agalactiae. In this model, BPL005 when co-cultured with those pathogens was shown to lower pH and to produce organic acids, being lactic acid the most relevant. The co-cultivation of strain L. rhamnosus BPL005 with tested reference pathogens produced a significant reduction in P. acnes and St. agalactiae levels and a non-significant reduction in A. vaginae and G. vaginalis. The colonization of L. rhamnosus BPL005 in the culture decreased IL-6, IL-8, and MCP-1, heightened in the presence of pathogens, and increased IL-1RA and IL-1 beta. Finally, safety was evaluated showing no signs of cytotoxicity, irritation in vaginal tests, or allergic contact dermatitis potential through the Local Lymph Node Assay. Overall, these results show the potential of L. rhamnosus BPL005 strain as a probiotic in gynecological health.https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/fullL. rhamnosus BPL005 (CECT 8800)endometrial healthgynecological pathogensprobioticpathogen inhibition |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Empar Chenoll Inmaculada Moreno Inmaculada Moreno María Sánchez Iolanda Garcia-Grau Iolanda Garcia-Grau Ángela Silva Marta González-Monfort Salvador Genovés Felipe Vilella Cristina Seco-Durban Carlos Simón Carlos Simón Carlos Simón Carlos Simón Daniel Ramón |
spellingShingle |
Empar Chenoll Inmaculada Moreno Inmaculada Moreno María Sánchez Iolanda Garcia-Grau Iolanda Garcia-Grau Ángela Silva Marta González-Monfort Salvador Genovés Felipe Vilella Cristina Seco-Durban Carlos Simón Carlos Simón Carlos Simón Carlos Simón Daniel Ramón Selection of New Probiotics for Endometrial Health Frontiers in Cellular and Infection Microbiology L. rhamnosus BPL005 (CECT 8800) endometrial health gynecological pathogens probiotic pathogen inhibition |
author_facet |
Empar Chenoll Inmaculada Moreno Inmaculada Moreno María Sánchez Iolanda Garcia-Grau Iolanda Garcia-Grau Ángela Silva Marta González-Monfort Salvador Genovés Felipe Vilella Cristina Seco-Durban Carlos Simón Carlos Simón Carlos Simón Carlos Simón Daniel Ramón |
author_sort |
Empar Chenoll |
title |
Selection of New Probiotics for Endometrial Health |
title_short |
Selection of New Probiotics for Endometrial Health |
title_full |
Selection of New Probiotics for Endometrial Health |
title_fullStr |
Selection of New Probiotics for Endometrial Health |
title_full_unstemmed |
Selection of New Probiotics for Endometrial Health |
title_sort |
selection of new probiotics for endometrial health |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular and Infection Microbiology |
issn |
2235-2988 |
publishDate |
2019-04-01 |
description |
Microbiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on its capacity to initially lower pH and to promote the reduction of pathogenic bacteria. Based on this rationale, strain Lactobacillus rhamnosus BPL005 was initially selected for its capacity to reduce in vitro pH levels and produce organic acids. Subsequently, strain L. rhamnosus BPL005 (CECT 8800) was demonstrated to have a protective role on endometrial infections in an in vitro model of bacterial colonization of primary endometrial epithelial cells with Atopobium vaginae, Gardnerella vaginalis, Propionibacterium acnes, and Streptococcus agalactiae. In this model, BPL005 when co-cultured with those pathogens was shown to lower pH and to produce organic acids, being lactic acid the most relevant. The co-cultivation of strain L. rhamnosus BPL005 with tested reference pathogens produced a significant reduction in P. acnes and St. agalactiae levels and a non-significant reduction in A. vaginae and G. vaginalis. The colonization of L. rhamnosus BPL005 in the culture decreased IL-6, IL-8, and MCP-1, heightened in the presence of pathogens, and increased IL-1RA and IL-1 beta. Finally, safety was evaluated showing no signs of cytotoxicity, irritation in vaginal tests, or allergic contact dermatitis potential through the Local Lymph Node Assay. Overall, these results show the potential of L. rhamnosus BPL005 strain as a probiotic in gynecological health. |
topic |
L. rhamnosus BPL005 (CECT 8800) endometrial health gynecological pathogens probiotic pathogen inhibition |
url |
https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/full |
work_keys_str_mv |
AT emparchenoll selectionofnewprobioticsforendometrialhealth AT inmaculadamoreno selectionofnewprobioticsforendometrialhealth AT inmaculadamoreno selectionofnewprobioticsforendometrialhealth AT mariasanchez selectionofnewprobioticsforendometrialhealth AT iolandagarciagrau selectionofnewprobioticsforendometrialhealth AT iolandagarciagrau selectionofnewprobioticsforendometrialhealth AT angelasilva selectionofnewprobioticsforendometrialhealth AT martagonzalezmonfort selectionofnewprobioticsforendometrialhealth AT salvadorgenoves selectionofnewprobioticsforendometrialhealth AT felipevilella selectionofnewprobioticsforendometrialhealth AT cristinasecodurban selectionofnewprobioticsforendometrialhealth AT carlossimon selectionofnewprobioticsforendometrialhealth AT carlossimon selectionofnewprobioticsforendometrialhealth AT carlossimon selectionofnewprobioticsforendometrialhealth AT carlossimon selectionofnewprobioticsforendometrialhealth AT danielramon selectionofnewprobioticsforendometrialhealth |
_version_ |
1724967805157113856 |